التداخل بين أدينوزين وديبيريدامول

Adenosinergic agents (e.g., adenosine, regadenoson) Dipyridamole has been reported to increase the plasma levels and cardiovascular effects of adenosine.

Adjustment of adenosine dosage may be necessary.

Dipyridamole also increases the cardiovascular effects of regadenoson, an adenosine A 2A -receptor agonist.

Nucleoside transport inhibitors such as dipyridamole can increase the activity of adenosine ( 7.1 )

The vasoactive effects of adenosine are potentiated by nucleoside transport inhibitors such as dipyridamole.

The safety and efficacy of adenosine in the presence of dipyridamole has not been systematically evaluated.